Dyne TherapeuticsDYN

那斯達克 · USD
19.70
-0.61
(-3.00%)
盤中 09/09 10:29 (UTC+8)
09/09 10:29 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
181,662125,276116,129113,892115,791-----
研發費用
152,286100,88995,43197,21999,236106,44781,80592,79962,26344,539
推銷及管理費用
29,37624,38720,69816,67316,55515,92515,30312,8609,69924,618
非經常性項目費用
----------
其他營業費用
----------
營業利益
-181,662
-125,276
-116,129
-113,892
-115,791
-122,372
-97,108
-105,659
-71,962
-69,157
其他收入及費用
7,7018,6247,3688,7565,0277,0117,5668,5346,8603,508
利息費用
4,5954,2023,1942,90494-----
稅前純益
-178,556
-120,854
-111,955
-108,040
-110,858
-115,361
-89,542
-97,125
-65,102
-65,649
所得稅
----------
稅後純益
-178,556
-120,854
-111,955
-108,040
-110,858
-115,361
-89,542
-97,125
-65,102
-65,649
基本每股稅後盈餘(元)
-1.08-0.73-0.76-0.76-0.97-1.05-0.88-0.96-0.70-0.81
稀釋每股稅後盈餘(元)
-1.08-0.73-0.73-0.72-0.97-1.05-0.88-0.98-0.70-0.81
基本平均股數(千股)
165451.00165036.00147618.00141810.00113873.00109911.00101982.00100882.0092507.0081043.00
稀釋平均股數(千股)
165451.00165036.00147618.00141810.00113873.00109911.00101982.00100882.0092507.0081043.00
還原基本每股稅後盈餘(元)
-1.08-0.73-0.76-0.76-0.97-1.05-0.88-0.96-0.70-0.81
還原稀釋每股稅後盈餘(元)
-1.08-0.73-0.73-0.72-0.97-1.05-0.88-0.98-0.70-0.81
還原基本平均股數(千股)
165,451165,036147,618141,810113,873109,911101,982100,88292,50781,043
還原稀釋平均股數(千股)
165,451165,036147,618141,810113,873109,911101,982100,88292,50781,043
EBITDA(千元)
-173,634-116,373-108,628-104,981-110,724-115,475-89,928-97,663-65,972-65,786

大家都在看

HOT